How long should I take Adagrasib?

The duration of use of Adagrasib (Adagrasib) is usually determined by the doctor based on the patient's specific condition and response to treatment. This is an individualized decision based on the patient's disease status, purpose of treatment, and drug tolerance.

Typically, adagrasib is given as part of long-term treatment, especially for patients with non-small cell lung cancer (NSCLC) who carry the KRAS G12C mutation. NSCLCIt is usually a chronic disease that requires long-term treatment to control the disease and provide patients with the best survival and quality of life.

Before starting adagrasiib treatment, patients usually receive a comprehensive evaluation, including physical condition, medical history, tumor characteristics and other aspects. Your doctor will use this information to develop an individualized treatment plan, which includes determining the initial dose of the drug and possible dose adjustments.

During the treatment process, patients need to undergo regular medical monitoring, including blood tests, imaging examinations, etc., to evaluate the efficacy of the drug and the patient's overall health. Based on the monitoring results, doctors may adjust the dose of adagrasib or take other measures to ensure the best therapeutic effect.

It should be emphasized that treatment with adagrasib is usually continued until the patient develops disease progression, becomes intolerant of the drug, or until the physician determines that other treatment options are more appropriate. For chronic diseases such as lung cancer, long-term maintenance of treatment is key to control tumor growth and provide patients with optimal survival and quality of life.

Adagrasib is not currently available in the country, so patients cannot purchase it domestically and can only purchase adagrasib through overseas channels. Abroad, there is only the original American drug adagrasib, and the price is very high, as high as about 190,000 yuan.